RDF/XML JSON-LD N3/Turtle RDF/JSON

Guijarro Herráiz, Carlos carlos.guijarro@urjc.es

Especialidades Médicas y Salud Pública / Universidad Rey Juan Carlos

Actividades

Mortality among adult patients admitted to the hospital on weekends

  • Barba, R.
  • Losa, J. E.
  • Velasco, M.
  • Guijarro, C.
  • Garcia de Casasola, G.
  • Zapatero, A.;

European Journal Of Internal Medicine (p. 322-324) - 1/8/2006

10.1016/j.ejim.2006.01.003 Ver en origen

  • ISSN 09536205

NEOPLASMS OF UNKNOWN PRIMARY SITE - A CLINICOPATHOLOGICAL STUDY OF AUTOPSIED PATIENTS

  • MAYORDOMO, JI
  • GUERRA, JM
  • GUIJARRO, C
  • GARCIAPRATS, MD
  • GOMEZ, A
  • LOPEZBREA, M
  • GONZALEZ, R
  • HERGUETA, P
  • LOPEZPINO, MA
  • MARTINEZTELLO, F
  • CORTESFUNES, H;
... Ver más Contraer

Tumori j (p. 321-324) - 31/10/1993

10.1177/030089169307900507 Ver en origen

  • ISSN 03008916

New proposals for improving the publication of clinical trials

  • Alfaro, V;

Medicina Clinica (p. 677-677) - 13/11/2004

10.1157/13068697 Ver en origen

  • ISSN 00257753

Occult vascular lesions in patients with atherothrombotic events: The AIRVAG cohort

  • Lujan, S
  • Puras, E
  • Lopez-Bescos, L
  • Belinchon, JC
  • Gutierrez, M
  • Guijarro, C;

European Journal Of Vascular And Endovascular Surgery (p. 57-62) - 1/7/2005

10.1016/j.ejvs.2005.02.019 Ver en origen

  • ISSN 10785884

Overall Mortality and LDL Cholesterol Reduction in Secondary Prevention Trials of Cardiovascular Disease

  • Pedro-Botet, Juan
  • Lopez-Miranda, Jose
  • Badimon, Lina
  • Civeira, Fernando
  • Guijarro, Carlos
  • Millan, Jesus
  • Mostaza, Jose M.
  • Pinto, Xavier
  • Valdivielso, Pedro
  • Masana, Luis;Expert Grp Spanish
... Ver más Contraer

American Journal Of Cardiovascular Drugs (p. 325-332) - 1/8/2020

10.1007/s40256-019-00376-y Ver en origen

  • ISSN 11753277

PCSK9 Inhibitors, Statins, Low-Density Lipoprotein Cholesterol, Mevalonate Pathway, and Toxicity

  • Guijarro, Carlos;

Jama Cardiology (p. 1168-+) - 1/10/2017

10.1001/jamacardio.2017.2727 Ver en origen

  • ISSN 23806583

PCSK9 inhibitors: Ratification of the role of LDL cholesterol in cardiovascular prevention. Towards a convergence of European and North American prevention guidelines?

  • Guijarro, C.
  • Camafort, M.;

Revista Clinica Espanola (p. 374-382) - 1/9/2020

10.1016/j.rce.2019.05.010 Ver en origen

  • ISSN 00142565

PLASMA MEVALONATE AND ITS IMPORTANCE IN NEPHROLOGY

  • MASSY, ZA
  • GUIJARRO, C
  • KASISKE, BL;

Nephrology Dialysis Transplantation (p. 1716-1718) - 1/1/1994

  • ISSN 13125257
  • iMarina

Peripheral arterial disease is a marker of risk for abdominal aortic aneurysms in patients with coronary artery disease

  • Guijarro, C
  • Lujan, S
  • Huelmos, AI
  • Puras, E
  • Lopez-Bescos, L;

American Journal Of Cardiology (p. 1549-1550) - 15/5/2006

10.1016/j.amjcard.2005.12.030 Ver en origen

  • ISSN 00029149

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study

  • Suarez Fernandez, M Carmen
  • Leiter, L A
  • Lundman, P
  • Da Silva, P M
  • Drexel, H
  • Junger, C
  • Gitt, A K
... Ver más Contraer

Diabetic Medicine (p. 1343-1351) - 1/11/2011

10.1111/j.1464-5491.2011.03360.x Ver en origen

  • ISSN 07423071

Este/a investigador/a no tiene libros.

Este/a investigador/a no tiene capítulos de libro.

A combination of alleles in TRAIL, TRAILR-1 and TRAILR-2 genes is associated with MS susceptibility

  • Lopez-Gomez, C.
  • Fernandez, O.
  • Garcia-Leon, J. A.
  • Pinto-Medel, M. J.
  • Oliver-Martos, B.
  • Ortega-Pinazo, J.
  • Orpez-Zafra, T.
  • Arnaiz-Urrutia, C.
  • Guijarro-Castro, C.
  • Benito-Leon, J.
  • Prat, I.
  • Varade, J.
  • Alvarez-Lafuente, R.
  • Urcelay, E.
  • Leyva, L.;REEM
... Ver más Contraer

Multiple Sclerosis Journal (p. S111-S111) - 1/10/2011

  • ISSN 13524585
  • iMarina

ASSOCIATION BETWEEN LOW HDL-C AND FAMILY HISTORY OF PREMATURE CORONARY HEART DISEASE IN SPANISH STATIN-TREATED PATIENTS. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)

  • Millan, J.
  • Gonzalez-Juanatey, J. R.
  • Guijarro, C.
  • Alegria, E.
  • Lozano, J. V.
  • Gonzalez-Timon, B.
  • Vitale, G.;
... Ver más Contraer

Atherosclerosis Supplements (p. 153-153) - 10/6/2010

10.1016/s1567-5688(10)70715-7 Ver en origen

  • ISSN 15675688

Ankle brachial index (ABI) is the single most relevant independent prognostic marker for recurrent vascular events. 5 years of follow up of the AIRVAG cohort

  • Lopez-Bescos, Lorenzo
  • Herreros, Benjamin
  • Huelmos, Ana I.
  • Puras, Enrique
  • Sanchez, Carmen
  • Gonzalez-Anglada, Isabel
  • Guijarro, Carlos;AIRVAG Invest
... Ver más Contraer

Circulation (p. 747-748) - 16/10/2007

  • ISSN 00097322
  • iMarina

Ankle-brachial index is a better predictor than C-reactive protein of new ischemic events in patients with clinical atherosclerosis. The AIRVAG cohort

  • Guijarro, C
  • Huelmos, AI
  • Belinchon, JC
  • Jimenez, J
  • Lujan, S
  • Puras, E
  • Sanchez, C
  • Cava, F
  • Lopez-Bescos, L;AIRVAG investigators
... Ver más Contraer

Circulation (p. 437-438) - 26/10/2004

  • ISSN 00097322
  • iMarina

Atorvastatin abolishes macrophage infiltration, and reduces neointimal formation and MCP-1 expression in a rabbit model of atherosclerosis. Role of nuclear factor kappa B

  • HernandezPresa, MA
  • Bustos, C
  • Ortego, M
  • Tunon, J
  • Guijarro, C
  • Diaz, C
  • Hernandez, G
  • Egido, J;
... Ver más Contraer

Circulation (p. 1621-1621) - 21/10/1997

  • ISSN 00097322
  • iMarina

Atorvastatin inhibition of NF-kappa B activation in vascular smooth muscle cells is mediated by protein isoprenylation blockade

  • Ortego, M
  • Bustos, C
  • HernandezPresa, M
  • Guijarro, C
  • Tunon, J
  • Egido, J;

Atherosclerosis (p. 131-131) - 1/10/1997

10.1016/s0021-9150(97)88709-6 Ver en origen

  • ISSN 00219150

Atorvastatin reduces lesion size and macrophage content in a rabbit model of atherosclerosis, and attenuates NF kappa B activation and MCP-1 expression in cultured VSMC.

  • Bustos, C
  • HernandezPresa, MA
  • Ortego, M
  • Tunon, J
  • Ortega, L
  • Guijarro, C
  • Diaz, C
  • Hernandez, G
  • Egido, J;
... Ver más Contraer

Atherosclerosis (p. 23-23) - 1/5/1997

  • ISSN 00219150
  • iMarina

BEYOND FARNESYL - ROLE OF GERANYLGERANYL(GG) IN HUMAN MESANGIAL CELL (HMC) DNA-SYNTHESIS STIMULATED BY PDGF

  • MASSY, ZA
  • KASISKE, BL
  • GUIJARRO, C
  • KIM, Y
  • KEANE, WF
  • ODONNELL, MP;

Journal Of The American Society Of Nephrology (p. 800-800) - 1/9/1995

  • ISSN 10466673
  • iMarina

CHARACTERISTICS OF PATIENTS WITH HIGH CLDL PLUS LOW CHDL AND/OR HIGH TG IN SPAIN. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)

  • Millan, J.
  • Gonzalez-Juanatey, J. R.
  • Alegria, E.
  • Guijarro, C.
  • Lozano, J. V.
  • Gonzalez-Timon, B.
  • Vitale, G.;
... Ver más Contraer

Atherosclerosis Supplements (p. 161-161) - 10/6/2010

10.1016/s1567-5688(10)70758-3 Ver en origen

  • ISSN 15675688

CHRONIC RENAL-ALLOGRAFT REJECTION AND CLINICAL-TRIAL DESIGN

  • KASISKE, BL
  • MASSY, ZA
  • GUIJARRO, C
  • MA, JZ;

Kidney International (p. S116-S119) - 1/12/1995

  • ISSN 00852538
  • iMarina

Este/a investigador/a no tiene documentos de trabajo.

Este/a investigador/a no tiene informes técnicos.

Este/a investigador/a no tiene proyectos de investigación.

Este/a investigador/a no tiene tesis dirigidas.

Este/a investigador/a no tiene patentes o licencias de software.

Última actualización de los datos: 24/04/24 13:20